These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 6086481)

  • 21. Nephrolithiasis and hyperparathyroidism.
    Broadus AE
    Hosp Pract (Off Ed); 1982 Jan; 17(1):98A, 98G-98H, 98L passim. PubMed ID: 6818128
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pathophysiology of primary hyperparathyroidism.
    Spiegel AM
    J Bone Miner Res; 1991 Oct; 6 Suppl 2():S15-7; discussion S31-2. PubMed ID: 1763667
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Increasing the detection of primary hyperparathyroidism. Critical analysis of the usefulness of the laboratory].
    Mahama D; Arteaga E; Rodríguez JA; Lopez JM
    Rev Med Chil; 1985 Jul; 113(7):696-8. PubMed ID: 3008287
    [No Abstract]   [Full Text] [Related]  

  • 24. Primary hyperparathyroidism.
    Cope O
    Nihon Hinyokika Gakkai Zasshi; 1968 Sep; 59(9):761-4. PubMed ID: 5750766
    [No Abstract]   [Full Text] [Related]  

  • 25. [Biochemical diagnosis of primary hyperparathyroidism].
    Frey H; Falch J; Hanssen K; Jørgensen H; Vaagen S; Rosenlund B; Torjesen P; Gautvik K
    Tidsskr Nor Laegeforen; 1982 Oct; 102(28):1441-6. PubMed ID: 6301096
    [No Abstract]   [Full Text] [Related]  

  • 26. Primary hyperparathyroidism viewed as a bihormonal disease process.
    Broadus AE
    Miner Electrolyte Metab; 1982; 8(3-4):199-214. PubMed ID: 6300631
    [No Abstract]   [Full Text] [Related]  

  • 27. Calcium homeostasis and the patogenesis and management of hypercalcemic disorders.
    Schneider AB; Sherwood LM
    Metabolism; 1974 Oct; 23(10):975-1007. PubMed ID: 4369823
    [No Abstract]   [Full Text] [Related]  

  • 28. Calcium infusion and phosphate deprivation tests in patients with primary hyperparathyroidism and with normocalcemia and nephrolithiasis.
    Schrott HG; Jubiz W; Frailey J; Tyler FH
    Metabolism; 1972 Mar; 21(3):205-11. PubMed ID: 5060761
    [No Abstract]   [Full Text] [Related]  

  • 29. Reversible resistance to the renal action of parathyroid hormone in human vitamin D deficiency.
    Lewin IG; Papapoulos SE; Hendy GN; Tomlinson S; O'Riordan JL
    Clin Sci (Lond); 1982 Apr; 62(4):381-7. PubMed ID: 6279352
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An estimation of the parathyroid hormone secretion rate in vitamin D deficient rats.
    Takahashi H; Shimazawa E; Horiuchi N; Suda T; Yamashita K; Ogata E
    Horm Metab Res; 1978 Mar; 10(2):161-7. PubMed ID: 206502
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization and evaluation of asymptomatic primary hyperparathyroidism.
    Bilezikian JP; Silverberg SJ; Shane E; Parisien M; Dempster DW
    J Bone Miner Res; 1991 Oct; 6 Suppl 2():S85-9; discussion S121-4. PubMed ID: 1662460
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The clinical, biochemical, operative and pathological analysis of 38 cases with primary hyperparathyroidism.
    Haddock L; Rabell V; Vázquez Plard J; Aguiló F; Vázquez MC; Vázquez Quintana E; de León E
    Bol Asoc Med P R; 1983 Apr; 75(4):159-66. PubMed ID: 6575788
    [No Abstract]   [Full Text] [Related]  

  • 33. Urinary excretion of cyclic adenosine monophosphate in the detection and diagnosis of primary hyperparathyroidism.
    Schmidt-Gayk H; Röher HD
    Surg Gynecol Obstet; 1973 Sep; 137(3):439-44. PubMed ID: 4352824
    [No Abstract]   [Full Text] [Related]  

  • 34. Maximal PTH secretory rate and set point for calcium in normal subjects and patients with primary hyperparathyroidism. In vivo studies.
    Gardin JP; Patron P; Fouqueray B; Prigent A; Paillard M
    Miner Electrolyte Metab; 1988; 14(4):221-8. PubMed ID: 2850460
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Diagnosis of primary hyperparathyroidism].
    Goischke HK
    Med Klin; 1980 Aug; 75(17):621-3. PubMed ID: 7412712
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [A scheme for the diagnosis of primary hyperparathyroidism (author's transl)].
    Hesch RD; McIntosh C; Lüderitz B; Hauswaldt C; Schuster R
    Dtsch Med Wochenschr; 1974 Dec; 99(50):2562-4, 2566-7, 2569-70. PubMed ID: 4375556
    [No Abstract]   [Full Text] [Related]  

  • 37. The effect of multiphasic biochemical screening on the diagnosis of primary hyperparathyroidism.
    Aitken RE; Bartley PC; Bryant SJ; Lloyd HM
    Aust N Z J Med; 1975 Jun; 5(3):224-6. PubMed ID: 1057934
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The renal sensitivity for endogenous parathormone in patients with primary hyperparathyroidism, vitamin D deficiency and renal stones.
    vd Velden PC; Fischer HR; Schopman W; van Roon F; Koorevaar G; Hackeng WH; Silberbusch J
    Horm Metab Res; 1986 Jul; 18(7):485-9. PubMed ID: 3017831
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Assay of parathyroid hormone in human serum and its uses.
    Woodhead JS; Walker DA
    Ann Clin Biochem; 1976 Nov; 13(6):549-54. PubMed ID: 1015786
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of short term glucocorticoid administration in primary hyperparathyroidism: comparison to sarcoidosis.
    Breslau NA; Zerwekh JE; Nicar MJ; Pak CY
    J Clin Endocrinol Metab; 1982 Apr; 54(4):824-30. PubMed ID: 6895899
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.